Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $36.47, but opened at $38.41. Bath & Body Works shares last traded at $39.40, with a volume of 1,137,123 shares changing hands.
Wall Street Analyst Weigh In
BBWI has been the topic of several research reports. JPMorgan Chase & Co. upgraded Bath & Body Works from a "neutral" rating to an "overweight" rating and raised their target price for the company from $41.00 to $47.00 in a research report on Tuesday. TD Cowen raised their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a research report on Thursday, December 12th. Barclays increased their price target on Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a report on Tuesday, November 26th. Piper Sandler increased their price target on Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Finally, Morgan Stanley cut their price target on Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a report on Thursday, November 21st. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.63.
View Our Latest Research Report on Bath & Body Works
Bath & Body Works Price Performance
The firm has a 50 day simple moving average of $37.70 and a 200-day simple moving average of $33.86. The company has a market cap of $8.34 billion, a price-to-earnings ratio of 9.39, a PEG ratio of 0.95 and a beta of 1.83.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.48 earnings per share. Research analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.08%. Bath & Body Works's dividend payout ratio (DPR) is 19.51%.
Institutional Investors Weigh In On Bath & Body Works
Several hedge funds and other institutional investors have recently added to or reduced their stakes in BBWI. Fifth Third Wealth Advisors LLC boosted its position in shares of Bath & Body Works by 4.9% during the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock worth $271,000 after buying an additional 324 shares during the period. SRS Capital Advisors Inc. boosted its position in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares during the period. TD Private Client Wealth LLC boosted its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after buying an additional 331 shares during the period. UMB Bank n.a. boosted its position in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after buying an additional 335 shares during the period. Finally, Northwest Bank & Trust Co boosted its position in shares of Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock worth $533,000 after buying an additional 419 shares during the period. Institutional investors and hedge funds own 95.14% of the company's stock.
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
